Eleventx
ScionxBio invites candidates to join a general talent pool for their multidisciplinary team engineering RNA medicines using synthetic chemistry and artificial intelligence. The organization seeks scientists and biotech professionals across operational and commercial functions at all career levels to contribute to their mission of creating long-acting therapeutics. Applicants are encouraged to express interest in specific areas like RNA biology or data science to receive future opportunities as roles open.
Headquarters
Cambridge, England, United Kingdom
Company Size
11-50 employees
Founded
2020
Eleven Therapeutics (ElevenTx) is a biotechnology company that combines combinatorial chemistry and machine learning to transform RNA interference (RNAi) drug discovery into a programmable, scalable process. Using a proprietary chemistry-and-AI platform, the company designs and optimizes RNAi molecules and associated chemistries to accelerate discovery and preclinical development. Its goal is to enable more rapid, predictable development of RNAi therapeutics across a range of genetic and acquired diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eleventx.
Eleventx didn’t post a salary, so this is our estimate from similar listings.
10% above the average for this role
Synthetic or Medicinal Chemist
mountsinaihospital.com
Postdoctoral Fellow – Oligonucleotide Therapies, Streamlining design through omics dissection of mRNA biology
AstraZeneca
Head of Lead ID
Eli Lilly and Company
SCIENTIST
Houston Methodist
Associate Scientist - Biology
Amgen
Expression of Interest – Chem Bio
The AI Security Institute (AISI)